CHLA has an internationally renowned team of medical professionals who use an interdisciplinary approach to treat children with blood disorders and who work continually to make advances in treating blood diseases. Our team represents a section of the Children’s Center for Cancer and Blood Diseases.
The focus of the hematology team is diagnosis, management and research for nonmalignant blood disorders. Physicians, nurse practitioners, clinical nurses, social workers and other caregivers offer our patients and their families special expertise, counseling and education in health maintenance, nutrition, and pain management. Annually, we treat 750 patients with a wide variety of blood disorders.
The hematology team providers are recognized for their range of clinical, teaching, research, and clinical trial achievements. We focus on genetic diseases that start at birth, some of which are quite rare. We partner with families to care for their children and work with adult providers to assure continued state of the art management and special expertise for patients of all ages with rare genetic blood diseases.
- General Hematology
- Hemostasis and Thrombosis
- Red Blood Cell Disorders
- Bone marrow failure
- acquired aplastic anemia
- genetic aplastic anemia
- Von Willebrand disease
- rare bleeding disorders
- Epidermolysis bullosa
- Iron overload
- Sickle cell disease, thalassemia and other red blood cell disorders
- White blood cell disorders
The Children’s Center for Cancer and Blood Diseases at CHLA is home to more major, multicenter clinical trials and research consortia than any other pediatric cancer program in the country. We offer the largest portfolio of pediatric, adolescent, and young adult clinical trials in the western United States, including several cutting-edge Phase 1, Phase 2 and Phase 3 clinical trials.
Please click here to see our Clinical Trials.
Please click here to see a list of our early phase trials, which are open to enrollment.
Health information maintained by the federal government's Department of Health and Human Services.
Organization offers support to thalassemia patients and their families.
Dedicated to finding better treatments and cures for bleeding and clotting disorders.
Founded in 1957, the Sickle Cell Disease Foundation of California (SCDFC) addresses the needs of individuals with sickle cell disease and their families by emphasizing educational and support programs.
A non-profit organization founded to help improve the quality of life for patients with thalassemia.